S S Thorgeirsson
- Molecular Biology top 5%
- Hepatology top 0.5%
- Pharmacology top 0.1%
- Oncology top 5%
- Cancer Research top 2%
- Co-authors
- John R. MitchellDavid J. JollowWilliam Z. PotterM HashimotoValentina M. FactorRitva P. EvartsPéter NagyJesper B. Andersen
- Topics
- Pharmacogenetics and Drug Metabolism (11 papers)Liver physiology and pathology (8 papers)Drug Transport and Resistance Mechanisms (6 papers)
- Partner nations
- United StatesUnited KingdomAustria
In The Last Decade
S S Thorgeirsson
43 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.7k
- Hepatology 1.2k
- Pharmacology 1.1k
- Oncology 881
- Cancer Research 760
Countries citing papers authored by S S Thorgeirsson
This map shows the geographic impact of S S Thorgeirsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Thorgeirsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Thorgeirsson more than expected).
Fields of papers citing papers by S S Thorgeirsson
This network shows the impact of papers produced by S S Thorgeirsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Thorgeirsson. The network helps show where S S Thorgeirsson may publish in the future.
Co-authorship network of co-authors of S S Thorgeirsson
This figure shows the co-authorship network connecting the top 25 collaborators of S S Thorgeirsson. A scholar is included among the top collaborators of S S Thorgeirsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S S Thorgeirsson. S S Thorgeirsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 64 | |
| 2 | Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesbreakdown → | 601 |
| 3 | 13 | |
| 4 | Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. | 110 |
| 5 | 3 | |
| 6 | 32 | |
| 7 | Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.breakdown → | 559 |
| 8 | The influence of pre-slaughter grazing management on carcass composition and meat quality in lambs. | 2 |
| 9 | 15 | |
| 10 | 153 | |
| 11 | 19 | |
| 12 | 69 | |
| 13 | 10 | |
| 14 | Metabolic activation: biochemical basis for many drug-induced liver injuries. | 52 |
| 15 | 34 | |
| 16 | 4 | |
| 17 | 33 | |
| 18 | 75 | |
| 19 | 50 | |
| 20 | Induction of drug metabolizing enzymes in man and rat by dichloralphenazone. | 5 |
About S S Thorgeirsson
S S Thorgeirsson is a scholar working on Pharmacology, Hepatology and Biochemistry, having authored 43 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Liver physiology and pathology (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Hepatology (1.2k citations), Pharmacology (1.1k citations) and Cancer Research (760 citations). S S Thorgeirsson has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include John R. Mitchell, David J. Jollow, William Z. Potter, M Hashimoto, Valentina M. Factor, Ritva P. Evarts, Péter Nagy, Jesper B. Andersen, Marian E. Durkin and Cédric Coulouarn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.